cyclophilin subtype selective inhibitor
/ SCYNEXIS, Cypralis
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 29, 2022
Discovery and molecular basis of subtype-selective cyclophilin inhibitors.
(PubMed, Nat Chem Biol)
- "We further exploited S2 pocket interactions to develop the first cyclophilin E (CypE)-selective inhibitor, which forms a reversible covalent bond with a CypE S2 pocket lysine, and exhibits 30- to >4,000-fold selectivity over other cyclophilins. These findings reveal a strategy to generate isoform-selective small-molecule cyclophilin modulators, advancing their suitability as targets for biological investigation and therapeutic development."
Journal • PPIF
1 to 1
Of
1
Go to page
1